0001209191-21-063207.txt : 20211105
0001209191-21-063207.hdr.sgml : 20211105
20211105170234
ACCESSION NUMBER: 0001209191-21-063207
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211103
FILED AS OF DATE: 20211105
DATE AS OF CHANGE: 20211105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lenington Rachel
CENTRAL INDEX KEY: 0001861194
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39503
FILM NUMBER: 211385420
MAIL ADDRESS:
STREET 1: C/O ATHIRA PHARMA, INC.
STREET 2: 18706 NORTH CREEK PARKWAY, SUITE 104
CITY: BOTHELL
STATE: WA
ZIP: 98011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Athira Pharma, Inc.
CENTRAL INDEX KEY: 0001620463
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 453368487
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18706 NORTH CREEK PARKWAY, SUITE 104
CITY: BOTHELL
STATE: WA
ZIP: 98011
BUSINESS PHONE: (425) 620-8501
MAIL ADDRESS:
STREET 1: 18706 NORTH CREEK PARKWAY, SUITE 104
CITY: BOTHELL
STATE: WA
ZIP: 98011
FORMER COMPANY:
FORMER CONFORMED NAME: M3 Biotechnology, Inc.
DATE OF NAME CHANGE: 20140924
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-11-03
0
0001620463
Athira Pharma, Inc.
ATHA
0001861194
Lenington Rachel
C/O ATHIRA PHARMA, INC.
18706 NORTH CREEK PARKWAY, SUITE 104
BOTHELL
WA
98011
0
1
0
0
Chief Operating Officer
Stock Option (Right to Buy)
15.34
2021-11-03
4
A
0
150000
0.00
A
2031-11-02
Common Stock
150000
150000
D
One-fourth of the shares subject to the option vest on June 14, 2022 and one-fourth of the shares subject to the option vest on each subsequent anniversary thereafter.
/s/ Glenna Mileson, Attorney in Fact for Rachel Lenington
2021-11-05